Company snapshot
Market Cap
$10B
Large-cap2016 — today
10-Year Price
+40%
2016 — today
52-Week Range
$141.17$244.18
Current $172.72· 31%
Featured in rankings
S&P500Most Undervalued Healthcare StocksBest Healthcare Dividend StocksBest Healthcare GARP StocksMost Undervalued Value StocksMost Undervalued Dividend StocksMost Undervalued Growth Stocks
Rankings recomputed after each US market close — see where UHS stands against peers.
Similar companies
| Company | P/E | Div yield |
|---|---|---|
| ZTSZoetis Inc. | 12.0 | 2.9% |
| ALCAlcon Inc. | 51.2 | 0.5% |
| CNCCentene Corporation | -6.3 | — |
| ALNYAlnylam Pharmaceuticals, Inc. | 41.8 | — |
| ONCBeOne Medicines Ltd. | 4.7 | — |
| AAgilent Technologies, Inc. | 28.2 | 0.5% |
| IDXXIDEXX Laboratories, Inc. | 35.9 | — |
| RVMDRevolution Medicines, Inc. | -23.0 | — |
Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.
Valuation in context
P/E ratio
7.1
Near historic low
Near historic low — last 10 years
Sector median 25.0below sector
P/B ratio
1.4
Near historic low
Near historic low — last 10 years
Sector median 2.5below sector
EV / EBITDA
5.5
Near historic low
Near historic low — last 10 years
Sector median 15.2below sector
Dividend Yield
0.5%
Above average
Above the 10-year average
Sector median 1.9%below sector
PEG ratio
0.5
Near historic low
Near historic low — last 10 years
Sector median 1.5below sector
FCF Yield
8.0%
Historically high
Historically high relative to the last 10 years
Sector median -10.0%above sector